Answers are grounded in this paper and cite their sources.
Innovative microfluidic architecture enhances lipid nanoparticle production, suggesting improvements in scalability and quality.
Lipid nanoparticles (LNPs) are a key platform for nucleic acid delivery, but their industrial-scale production remains a critical bottleneck. While microfluidics ensures high-quality LNP production, conventional single layer strategies suffer...
No takes yet. Share an insight, caveat, or question.
Jung et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: